Robert W Breckon Syneos Health, Inc. (SYNH) insider trading activity

Robert W Breckon is Director of Syneos Health, Inc.. Currently has a direct ownership of 6,057 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on May 23, 2017, when has been sold 2,693 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.06K

0% 3M change

0% 12M change

Total Value Held $0

Robert W Breckon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2017	BUY Grant, award, or other acquisition	-	2,693 Added 30.78%	6,057 Class A Common Stock
Sep 26 2016	SELL Open market or private sale	$540,327 $44.3 p/Share	12,197 Reduced 78.38%	3,364 Class A Common Stock
Sep 26 2016	BUY Exercise of conversion of derivative security	$64,220 $8.45 p/Share	7,600 Added 32.81%	15,561 Class A Common Stock
Aug 01 2016	SELL Open market or private sale	$4,536 $42.0 p/Share	108 Reduced 1.34%	7,961 Class A Common Stock
Jul 01 2016	SELL Open market or private sale	$15,985 $37.97 p/Share	421 Reduced 4.96%	8,069 Class A Common Stock
Jun 02 2016	SELL Open market or private sale	$94,439 $43.46 p/Share	2,173 Reduced 20.38%	8,490 Class A Common Stock
Jun 01 2016	SELL Open market or private sale	$414,509 $43.55 p/Share	9,518 Reduced 47.16%	10,663 Class A Common Stock
Jun 01 2016	BUY Exercise of conversion of derivative security	$80,427 $8.45 p/Share	9,518 Added 46.09%	11,134 Class A Common Stock
May 24 2016	BUY Grant, award, or other acquisition	-	2,231 Added 17.3%	10,663 Class A Common Stock
Feb 04 2016	SELL Open market or private sale	$154,348 $39.76 p/Share	3,882 Reduced 31.53%	8,432 Class A Common Stock
Feb 04 2016	BUY Exercise of conversion of derivative security	$23,550 $8.45 p/Share	2,787 Added 19.9%	11,219 Class A Common Stock
Aug 12 2015	SELL Payment of exercise price or tax liability	$33,981 $48.2 p/Share	705 Reduced 3.79%	17,908 Class A Common Stock
Aug 12 2015	SELL Open market or private sale	$368,764 $44.0 p/Share	8,381 Reduced 46.8%	9,527 Class A Common Stock
Aug 12 2015	BUY Exercise of conversion of derivative security	$31,003 $8.45 p/Share	3,669 Added 16.47%	18,613 Class A Common Stock
Jun 05 2015	BUY Grant, award, or other acquisition	-	1,700 Added 10.21%	14,944 Class A Common Stock
May 11 2015	SELL Open market or private sale	$21,399 $29.68 p/Share	721 Reduced 5.16%	13,244 Class A Common Stock
May 11 2015	SELL Payment of exercise price or tax liability	$4,092 $32.22 p/Share	127 Reduced 0.93%	13,602 Class A Common Stock
May 11 2015	BUY Exercise of conversion of derivative security	$4,098 $8.45 p/Share	485 Added 3.41%	13,729 Class A Common Stock
May 07 2015	SELL Open market or private sale	$244,148 $29.68 p/Share	8,226 Reduced 37.68%	13,607 Class A Common Stock
May 07 2015	SELL Payment of exercise price or tax liability	$46,717 $32.33 p/Share	1,445 Reduced 7.55%	17,688 Class A Common Stock
May 07 2015	BUY Exercise of conversion of derivative security	$46,695 $8.45 p/Share	5,526 Added 22.41%	19,133 Class A Common Stock

RWB

Robert W Breckon

Director

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Value

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syneos Health, Inc.

Track Activities on SYNH

Account